Literature DB >> 11837801

Racial differences in parathyroid hormone levels in patients with secondary hyperparathyroidism.

B P Sawaya1, M C Monier-Faugere, P Ratanapanichkich, R Butros, P J Wedlund, P Fanti.   

Abstract

AIM: African-Americans (AA) with normal renal function have higher parathyroid hormone (PTH) levels than Caucasians (C). This difference was also noted in cross-sectional studies of patients on dialysis. In this study, we evaluated patients with end-stage renal disease who have just began dialysis and who were not receiving any vitamin D therapy.
METHODS: A total of 363 patients were recruited (C: 260; AA: 103). All patients had serum calcium, phosphorus, alkaline phosphatase and intact PTH (iPTH) levels measured within 3 months of initiating dialysis.
RESULTS: Serum PTH levels were significantly higher in AA vs. C (383 +/- 33 vs. 246 +/- 19, p < 0.001). This difference was present despite similar calcium, phosphorus and alkaline phosphatase levels between the 2 groups and regardless of gender or diabetes status. However, PTH levels in patients younger than 47 years of age were similar in both groups.
CONCLUSION: PTH levels in ESRD patients over 47 years of age are higher in AA compared to C. The difference is, in part, due to an age-dependent reduction in PTH seen only in C. Further studies are needed to understand the mechanisms of these racial differences and to verify whether they mirror similar alterations at the level of the end-organ tissue.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11837801     DOI: 10.5414/cnp57051

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  12 in total

Review 1.  Disturbances in calcium metabolism and cardiomyocyte necrosis: the role of calcitropic hormones.

Authors:  Jawwad Yusuf; M Usman Khan; Yaser Cheema; Syamal K Bhattacharya; Karl T Weber
Journal:  Prog Cardiovasc Dis       Date:  2012 Jul-Aug       Impact factor: 8.194

2.  Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients.

Authors:  Hartmut H Malluche; Hanna W Mawad; Marie-Claude Monier-Faugere
Journal:  J Bone Miner Res       Date:  2011-06       Impact factor: 6.741

3.  Intracellular calcium overloading and oxidative stress in cardiomyocyte necrosis via a mitochondriocentric signal-transducer-effector pathway.

Authors:  Mazen Shaheen; Yaser Cheema; Atta U Shahbaz; Syamal K Bhattacharya; Karl T Weber
Journal:  Exp Clin Cardiol       Date:  2011

Review 4.  Cellular and molecular pathways to myocardial necrosis and replacement fibrosis.

Authors:  Malay S Gandhi; German Kamalov; Atta U Shahbaz; Syamal K Bhattacharya; Robert A Ahokas; Yao Sun; Ivan C Gerling; Karl T Weber
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

Review 5.  Fibrosis in hypertensive heart disease: molecular pathways and cardioprotective strategies.

Authors:  Atta U Shahbaz; Yao Sun; Syamal K Bhattacharya; Robert A Ahokas; Ivan C Gerling; Jesse E McGee; Karl T Weber
Journal:  J Hypertens       Date:  2010-09       Impact factor: 4.844

6.  Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisited.

Authors:  Brian J Borkowski; Yaser Cheema; Atta U Shahbaz; Syamal K Bhattacharya; Karl T Weber
Journal:  Eur Heart J       Date:  2011-03-12       Impact factor: 29.983

7.  Prevalence of CKD-MBD in pre-dialysis patients using biochemical markers in Enugu, South-East Nigeria.

Authors:  Julius U Okoye; Ejikeme B Arodiwe; Ifeoma I Ulasi; Chinwuba K Ijoma; Obinna D Onodugo
Journal:  Afr Health Sci       Date:  2015-09       Impact factor: 0.927

8.  Ethnicity, socioeconomic status, and attainment of clinical practice guideline standards in dialysis patients in the United kingdom.

Authors:  Udaya P Udayaraj; Yoav Ben-Shlomo; Paul Roderick; Retha Steenkamp; David Ansell; Charles R V Tomson; Fergus J Caskey
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-08       Impact factor: 8.237

Review 9.  Myocardial remodeling in low-renin hypertension: molecular pathways to cellular injury in relative aldosteronism.

Authors:  Syamal K Bhattacharya; Malay S Gandhi; German Kamalov; Robert A Ahokas; Yao Sun; Ivan C Gerling; Karl T Weber
Journal:  Curr Hypertens Rep       Date:  2009-12       Impact factor: 5.369

Review 10.  Mineralocorticoid receptor antagonism confers cardioprotection in heart failure.

Authors:  Michael R Seawell; Fahed Al Darazi; Victor Farah; Kodangudi B Ramanathan; Kevin P Newman; Syamal K Bhattacharya; Karl T Weber
Journal:  Curr Heart Fail Rep       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.